Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations:: an update

被引:22
作者
Karhu, Auli [1 ]
Aaltonen, Lauri A. [1 ]
机构
[1] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland
关键词
D O I
10.1093/hmg/ddm036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pituitary tumors are common intracranial neoplasms. Although histologically benign, pituitary tumors can cause significant morbidity due to their critical location, expanding size and oversecretion of pituitary hormone expression. The majority of pituitary tumors are sporadic, but some arise as a component of hereditary syndromes. Our understanding of these genetic conditions has expanded rapidly due to the identification of new predisposing genes. Four specific genes have been identified that predispose to hereditary pituitary neoplasia; MEN1, PRKAR1A, CDKNlB and AIP, of which CDKNlB and AIP have been identified only recently. These genes underlie multiple endocrine neoplasia type 1, Carney complex, MEN1-like phenotype and pituitary adenoma predisposition, respectively. The present study review the current state of knowledge regarding the genes associated to inherited pituitary neoplasia, with a particular focus on the novel pituitary adenoma predisposing genes, CDKN1B and AIP.
引用
收藏
页码:R73 / R79
页数:7
相关论文
共 52 条
  • [11] De Menis Ernesto, 2002, Pituitary, V5, P11
  • [12] Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma
    Drosten, M
    Hilken, G
    Böckmann, M
    Rödicker, F
    Mise, N
    Cranston, AN
    Dahmen, U
    Ponder, BAJ
    Pützer, BM
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (16): : 1231 - 1239
  • [13] Molecular pathogenesis of pituitary tumors
    Farrell, WE
    Clayton, RN
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 2000, 21 (03) : 174 - 198
  • [14] Fritz A, 2002, CANCER RES, V62, P3048
  • [15] Familial acromegaly
    Frohman, LA
    Eguchi, K
    [J]. GROWTH HORMONE & IGF RESEARCH, 2004, 14 : S90 - S96
  • [16] The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo
    Froidevaux, Marie-Stephanie Clerget
    Berg, Petra
    Seugnet, Isabelle
    Decherf, Stephanie
    Becker, Nathalie
    Sachs, Laurent M.
    Bilesimo, Patrice
    Nygard, Maria
    Pongratz, Ingemar
    Demeneix, Barbara A.
    [J]. EMBO REPORTS, 2006, 7 (10) : 1035 - 1039
  • [17] GEORGITSI M, 2006, BRIT J CANCER, V96, P352
  • [18] Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations
    Georgitsi, Marianthi
    Raitila, Anniina
    Karhu, Auli
    Tuppurainen, Karoliina
    Makinen, Markus J.
    Vierimaa, Outi
    Paschke, Ralf
    Saeger, Wolfgang
    van der Luijt, Rob B.
    Sane, Timo
    Robledo, Mercedes
    De Menis, Ernesto
    Weil, Robert J.
    Wasik, Anna
    Zielinski, Grzegorz
    Lucewicz, Olga
    Lubinski, Jan
    Launonen, Virpi
    Vahteristo, Pia
    Aaltonen, Lauri A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (10) : 4101 - 4105
  • [19] Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations:: analysis of 20 Japanese sporadic cases with MEN1
    Hai, N
    Aoki, N
    Shimatsu, A
    Mori, T
    Kosugi, S
    [J]. CLINICAL ENDOCRINOLOGY, 2000, 52 (04) : 509 - 518
  • [20] Molecular targets in pituitary tumours
    Heaney, AP
    Melmed, S
    [J]. NATURE REVIEWS CANCER, 2004, 4 (04) : 285 - 295